CircZFR is highly expressed in cancer-associated fibroblasts (CAFs) and their exosomes, and can be transferred to HCC cells, where it inhibits the STAT3/NF-κB signaling pathway, promoting tumor growth and increasing resistance to DDP (Zhou et al., 2022). This evidence concerns the gene STAT3 and hepatocellular carcinoma.